Identification of new possible targets for leukemia treatment by kinase activity profiling

References

• Kantarjian H, Sawyers C, Hochhaus A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002;346:645–652.
   PubMed Web of Science ®Google Scholar
• Kornblau SM, Womble M, Qiu YH, et al. Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. Blood 2006;108:2358–2365.
   PubMed Web of Science ®Google Scholar
• Tyner JW, Walters DK, Willis SG, et al. RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. Blood 2008;111:2238–2245.
   PubMed Web of Science ®Google Scholar
• Lemeer S, Ruijtenbeek R, Pinkse MW, et al. Endogenous phosphotyrosine signaling in zebrafish embryos. Mol Cell Proteomics 2007;6:2088–2099.
   PubMed Web of Science ®Google Scholar
• Dokter WH, Tuyt L, Sierdsema SJ, Esselink MT, Vellenga E. The spontaneous expression of interleukin-1 beta and interleukin-6 is associated with spontaneous expression of AP-1 and NF-kappa B transcription factor in acute myeloblastic leukemia cells. Leukemia 1995;9:425–432.
   PubMed Web of Science ®Google Scholar
• Sikkema AH, Diks SH, den Dunnen WF, et al. Kinome profiling in pediatric brain tumors as a new approach for target discovery. Cancer Res 2009;69:5987–5995.
   PubMed Web of Science ®Google Scholar
• Hilhorst R, Houkes L, van den BA, Ruijtenbeek R. Peptide microarrays for detailed, high-throughput substrate identification, kinetic characterization, and inhibition studies on protein kinase A. Anal Biochem 2009;387:150–161.
   PubMed Web of Science ®Google Scholar
• Zwaan CM, Kaspers GJ, Pieters R, et al. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood 2000;96:2879–2886.
   PubMed Web of Science ®Google Scholar
• Diks SH, Parikh K, van der SM, et al. Evidence for a minimal eukaryotic phosphoproteome? PLoS ONE 2007;2:e777.
   PubMed Web of Science ®Google Scholar
• Foss B, Ulvestad E, Bruserud O. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. Eur J Haematol 2001;67:267–278.
   PubMed Web of Science ®Google Scholar
• Tsai LH, White L, Raines E, et al. Expression of platelet-derived growth factor and its receptors by two pre-B acute lymphocytic leukemia cell lines. Blood 1994;83:51–55.
   PubMed Web of Science ®Google Scholar
• Hiwatari M, Ono R, Taki T, et al. Novel gain-of-function mutation in the extracellular domain of the PDGFRA gene in infant acute lymphoblastic leukemia with t(4;11)(q21;q23). Leukemia 2008;22:2279–2280.
   PubMed Web of Science ®Google Scholar
• Li Z, Beutel G, Rhein M, et al. High-affinity neurotrophin receptors and ligands promote leukemogenesis. Blood 2009;113:2028–2037.
   PubMed Web of Science ®Google Scholar
• Kornblau SM, Womble M, Qiu YH, et al. Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. Blood 2006;108:2358–2365.
   PubMed Web of Science ®Google Scholar
• Milella M, Kornblau SM, Estrov Z, et al. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. J Clin Invest 2001;108:851–859.
   PubMed Web of Science ®Google Scholar
• Kim SC, Hahn JS, Min YH, et al. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. Blood 1999;93:3893–3899.
   PubMed Web of Science ®Google Scholar
• Raimondi SC, Chang MN, Ravindranath Y, et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999;94:3707–3716.
   PubMed Web of Science ®Google Scholar
• Kerr AH, James JA, Smith MA, et al. An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia. Ann NY Acad Sci 2003;1010:86–89.
   PubMed Web of Science ®Google Scholar
• James JA, Smith MA, Court EL, et al. An investigation of the effects of the MEK inhibitor U0126 on apoptosis in acute leukemia. Hematol J 2003;4:427–432.
   PubMedGoogle Scholar
• Stegmaier K, Corsello SM, Ross KN, et al. Gefitinib induces myeloid differentiation of acute myeloid leukemia. Blood 2005;106:2841–2848.
   PubMed Web of Science ®Google Scholar
• Boehrer S, Ades L, Braun T, et al. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood 2008;111:2170–2180.
   PubMed Web of Science ®Google Scholar
• Lindhagen E, Eriksson A, Wickstrom M, et al. Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia. Eur J Haematol 2008;81:344–353.
   Google Scholar
• Spengeman JD, Green TD, McCubrey JA, Bertrand FE. Activated EGFR promotes the survival of B-lineage acute leukemia in the absence of stromal cells. Cell Cycle 2005;4:483–487.
   PubMed Web of Science ®Google Scholar
• Wang MH, Yao HP, Zhou YQ. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers. Acta Pharmacol Sin 2006;27:641–650.
   PubMed Web of Science ®Google Scholar
• Bardella C, Costa B, Maggiora P, et al. Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression. Cancer Res 2004;64:5154–5161.
   PubMed Web of Science ®Google Scholar
• Angeloni D, Nilkovitch-Miagkova A, Ivanova T, et al. Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter. Oncogene 2007;26:4499–4512.
   Google Scholar
• Gossage L, Eisen T. Targeting multiple kinase pathways: a change in paradigm. Clin Cancer Res 2010;16:1973–1978.
   PubMed Web of Science ®Google Scholar